Prolia

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®

Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

Study of CMAB807 Post-change in Manufacturing Site and Prolia in Healthy Volunteers

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

AVT03 With Prolia in Healthy Male Subjects

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS

Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults

A Study to Evaluate LY06006 and Prolia in Healthy Adults

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults

Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers

Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults